Physician profile
Augustine Joseph
NPI 1750360459
$23,635.15
in general payments reported to CMS, 2019-2025
60 companies · $1,792 in 2025
The $1,792 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,002 · 2020: $2,923 · 2021: $3,477 · 2022: $4,053 · 2023: $3,804 · 2024: $4,585 · 2025: $1,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $33.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,147.03 |
| Education | $33.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,862.56 | 2020-2025 | |
| Acadia Pharmaceuticals INC | $1,717.30 | 2019-2025 | Nuplazid |
| Biogen, INC. | $1,487.76 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Teva Pharmaceuticals USA, INC. | $1,411.48 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Lilly USA, LLC | $1,324.68 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Amgen INC. | $1,159.13 | 2019-2025 | Uplizna, Aimovig |
| Mdd US Operations, LLC | $1,099.20 | 2019-2025 | Gocovri, Xadago, Gocovri |
| Ucb, INC. | $1,067.87 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Eisai INC. | $933.02 | 2020-2025 | |
| Sk Life Science, INC. | $769.98 | 2020-2025 | |
| Tanabe Pharma America, INC. | $675.56 | 2019-2025 | Radicava |
| Novartis Pharmaceuticals Corporation | $660.07 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $628.38 | 2020-2025 | Ingrezza |
| Pfizer INC. | $596.19 | 2021-2025 | |
| Argenx US, INC. | $568.15 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustine Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.